Key result
Transcatheter closure of atrial septal defects without fluoroscopy yielded similar procedure times to the conventional procedure but required higher propofol doses.
Why the study?
Does transcatheter closure under echocardiographic guidance without fluoroscopy maintain procedural efficiency compared to conventional fluoroscopic procedures in patients with atrial septal defects or patent foramen ovale?
Cohort (n=153)
Does transcatheter closure under echocardiographic guidance without fluoroscopy maintain procedural efficiency compared to conventional fluoroscopic procedures in patients with atrial septal defects or patent foramen ovale?
Transcatheter closure of atrial septal defects and patent foramen ovale can be safely performed without fluoroscopy using echocardiographic guidance, yielding similar procedure times but requiring higher sedation doses.
Answers are grounded in this paper and cite their sources.
Demonstrates feasibility of fluoroscopy-free echo-guided ASD/PFO closure; leaves open whether this approach warrants routine adoption without larger trials.
BACKGROUND: In an effort to reduce x-ray exposure, we developed a technique for transcatheter closure of atrial septal defects under echocardiographic guidance without fluoroscopy. To assess the efficiency of this procedure for routine use, we compared our initial results with those for the conventional procedure. METHODS AND RESULTS: Twenty-two randomly selected patients (median age 18 years; range 2 to 66 years) with atrial septal defects (n=13) or patent foramen ovale (n=9) underwent cardiac catheterization for possible interventional defect closure with echocardiography as the only imaging tool. Median stretched diameter was 9 mm (range 6 to 26 mm); median left-to-right shunt over the atrial septal defects was Qp/Qs=1.8 (range 1.5 to 2.6). An Amplatzer septal occluder was successfully implanted in 19 defects without fluoroscopy and in 3 with the help of radiography. After 1 month, complete defect closure was documented in all patients. Compared with the conventional procedure of a control group of 131 patients, procedure times were not significantly different (88 versus 100 minutes; P=0.09). However, the study group received significantly higher doses of propofol for sedation (9.9 versus 5.6 mg/kg body weight; P=0.002) owing to extended transesophageal echocardiography. CONCLUSIONS: In the majority of patients in whom transcatheter closure of interatrial communications with the Amplatzer septal occluder is possible, the procedure can be safely performed under echocardiographic guidance without fluoroscopy.
No takes yet. Share an insight, caveat, or question.
Ewert et al. (2000) conducted a cohort in Atrial septal defects or patent foramen ovale (n=153). Transcatheter closure under echocardiographic guidance without fluoroscopy vs. Conventional procedure (with fluoroscopy) was evaluated on Procedure times (minutes) (p=0.09). Transcatheter closure of atrial septal defects without fluoroscopy yielded similar procedure times to the conventional procedure but required higher propofol doses.
Synapse has enriched 10 related papers. Consider them for comparative context: